An active part of Artemisia sacrorum Ledeb. suppresses gluconeogenesis through AMPK mediated GSK3β and CREB phosphorylation in human HepG2 cells

Bioscience, Biotechnology and Biochemistry

Volumn 75, Issue 6, 2011, Pages 1079-1084

  Yuan, Hai Dan ^a,b   Piao, Guang Chun ^a  

^a YANBIAN UNIVERSITY   (China)

^b Kyung Hee University   (South Korea)

Author keywords

AMP activated protein kinase; Artemisia sacrorum Ledeb.; Glucose production

Indexed keywords

ACETYL-COA CARBOXYLASE; ACTIVE PARTS; AMP-ACTIVATED PROTEIN KINASE; ARTEMISIA SACRORUM LEDEB.; COMPOSITAE; CONCENTRATION-DEPENDENT; ELEMENT-BINDING PROTEINS; ENZYME PHOSPHORYLATION; GLUCONEOGENESIS; GLUCOSE PRODUCTION; GLUCOSE-6-PHOSPHATASE; GLYCOGEN SYNTHASE KINASE-3; HEPG2 CELLS; HETERODIMERS; NUCLEAR RECEPTORS; PETROLEUM ETHER; PHOSPHOENOLPYRUVATE CARBOXYKINASE; PRE-TREATMENT;

CONCENTRATION (PROCESS); CYTOLOGY; ENZYME ACTIVITY; ETHERS; FETAL MONITORING; GENES; GLUCOSE; METABOLISM; TRANSCRIPTION; TRANSCRIPTION FACTORS;

PHOSPHORYLATION;

ACETYL COENZYME A CARBOXYLASE; ANTIDIABETIC AGENT; CELL RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN SYNTHASE KINASE; HEAT SHOCK PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PLANT EXTRACT; PPARGC1A PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR;

ARTEMISIA; ARTICLE; BIOSYNTHESIS; CELL STRAIN HEPG2; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENETICS; GLUCONEOGENESIS; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ARTEMISIA; BLOTTING, WESTERN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE; GLUCOSE-6-PHOSPHATASE; GLYCOGEN SYNTHASE KINASES; HEAT-SHOCK PROTEINS; HEP G2 CELLS; HUMANS; HYPOGLYCEMIC AGENTS; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PHOSPHORYLATION; PLANT EXTRACTS; PROTEIN KINASE INHIBITORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

ARTEMISIA GMELINII; ASTERACEAE;

EID: 79959561822     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.100881     Document Type: Article

References (25)

1. Kim YM, Namkoong S, Yun YG, Hong HD, Lee YC, Ha KS, Lee H, Kwon HJ, Kwon YG, and Kim YM, Biol. Pharm. Bull., 30, 1674-1679 (2007).
2. Tuttle KR, McGill JB, Haney DJ, Lin TE, and Anderson PW, Clin. J. Am. Soc. Nephrol., 2, 631-636 (2007).
3. Liao Z, Chen X, and Wu M, Arch. Pharm. Res., 33, 353-362 (2010).
4. Zhu CF, Peng HB, Liu GQ, Zhang F, and Li Y, Nutrition, 26, 1014-1020 (2010).
5. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P, Takemori H, and Montminy M, Nature, 437, 1109-1111 (2005).
6. Nagashima T, Shigematsu N, Maruki R, Urano Y, Tanaka H, Shimaya A, Shimokawa T, and Shibasaki M, Mol. Pharmacol., 78, 961-970 (2010).
7. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, and Moller DE, J. Clin. Invest., 108, 1167-1174 (2001).
8. Lin CL, Huang HC, and Lin JK, J. Lipid Res., 48, 2334-2343 (2007).
9. Mues C, Zhou J, Manolopoulos KN, Korsten P, Schmoll D, Klotz LO, Bornstein SR, Klein HH, and Barthel A, Horm. Metab. Res., 41, 730-735 (2009).
10. Horike N, Sakoda H, Kushiyama A, Ono H, Fujishiro M, Kamata H, Nishiyama K, Uchijima Y, Kurihara Y, Kurihara H, and Asano T, J. Biol. Chem., 283, 33902-33910 (2008).
11. Misra P and Chakrabarti R, Indian J. Med. Res., 125, 389-398 (2007).
12. Carling D, Trends Biochem. Sci., 29, 18-24 (2004).
13. Rao SD and Pagidas K, Anticancer Res., 30, 2519-2523 (2010).
14. Akli S, Chelly J, Lacorte JM, Poenaru L, and Kahn A, Genomics, 11, 124-134 (1991).
15. Kitazawa M, Ohizumi Y, Oike Y, Hishinuma T, and Hashimoto S, J. Pharmacol. Exp. Ther., 323, 787-793 (2007).
16. Yan ZK and Li WL, People's Health Publishing House, 415 (1997).
17. Yuan HD, Yuan HY, Chung SH, Jin GZ, and Piao GC, Biosci. Biotechnol. Biochem., 74, 322-328 (2010).
18. Agius L, Best Pract. Res. Clin. Endocrinol. Metab., 21, 587-605 (2007).
19. Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, Andreelli F, and Foretz M, Acta Physiol., 196, 81-98 (2009).
20. Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, and Andreelli F, J. Physiol., 574, 41-53 (2006).
21. Brusq JM, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y, and Issandou M, J. Lipid Res., 47, 1281-1288 (2006).
22. Ha do T, Trung TN, Hien TT, Dao TT, Yim N, Ngoc TM, Oh WK, and Bae K, J. Ethnopharmacol., 131, 417-424 (2010).
23. Lee JM, Seo WY, Song KH, Chanda D, Kim YD, Kim DK, Lee MW, Ryu D, Kim YH, Noh JR, Lee CH, Chiang JY, Koo SH, and Choi HS, J. Biol. Chem., 285, 32182-32191 (2010).
24. Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, Jang WG, Cho WJ, Ha J, Lee IK, Lee CH, and Choi HS, Diabetes, 57, 306-314 (2008).
25. Chanda D, Kim SJ, Lee IK, Shong M, and Choi HS, Am. J. Physiol. Endocrinol. Metab., 295, E368-E379 (2008).